Symptomatic CAPS is accompanied by a striking acute-phase response, with serum concentrations of C-reactive protein (CRP) and serum amyloid A protein (SAA) frequently elevated by 100- to 1,000-fold, underlying the high risk of AA amyloidosis [10,12]. Here, CRP is linked to AA amyloidosis.